These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7701)

  • 21. [A cross-over study of ketanserin compared to placebo, beta-adrenergic blockader, diuretic and alpha 1-adrenergic blockader. Cooperative research in the USSR (the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension). Working Group (4)].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(9):91-6. PubMed ID: 1684678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct].
    Golikov AP; Orlov AI; Ivleva VI; Stepura OB
    Kardiologiia; 1980 Oct; 20(10):35-40. PubMed ID: 6108378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 25. [Efficacy of treatment with inderal and visken of patients with circulatory insufficiency].
    Shevchenko IA; Marchenko AM; Simonenko VB
    Voen Med Zh; 1983 Feb; (2):51-3. PubMed ID: 6133395
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of anapriline on myocardial contraction and systemic vascular resistance in patients with stage II hypertension].
    Tokarenko II
    Klin Med (Mosk); 1990 Dec; 68(12):15-7. PubMed ID: 1982154
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemodynamic correlates of selective beta 1 adrenergic receptor blockade by cordanum during hemiton monotherapy in children with primary arterial hypertension].
    Kapliev VA
    Pediatriia; 1988; (9):112. PubMed ID: 2904673
    [No Abstract]   [Full Text] [Related]  

  • 28. [Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol].
    Shmidt Iu; Khomut V; Monike V; Bakh Kh; Fliugel' Kh
    Kardiologiia; 1985 Jun; 25(6):110-1. PubMed ID: 2864466
    [No Abstract]   [Full Text] [Related]  

  • 29. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
    Lil'in ET; Vavilova TA; Mar'in MI
    Klin Med (Mosk); 1983 Sep; 61(9):85-9. PubMed ID: 6139506
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of a new beta-receptor blockader (LB 46, Visken) on systemic and pulmonary hemodynamics and on coronary blood flow in humans].
    Dolder M; Kaufmann M; Gurtner HP
    Schweiz Med Wochenschr; 1971 Dec; 101(51):1869-76. PubMed ID: 4400986
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemodynamic effects of hypotensive agents under adrenergic block in hypertension].
    Shchepotin BM; Kazak LI; Guseva NP; Prisiazhniuk MS
    Kardiologiia; 1981 Mar; 21(3):38-41. PubMed ID: 6112286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of antihypertensive drugs.
    Itskovitz HD
    Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
    Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
    Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
    Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of prindolol (Visken) in the treatment of hypertension.
    Morgan TO; Louis WJ; Dawborn JK; Doyle AE
    Med J Aust; 1972 Aug; 2(6):309-12. PubMed ID: 4404279
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of anaprilin on cardiac hemodynamic indices in elderly hypertensive patients].
    Severova NL
    Vrach Delo; 1983 May; (5):26-30. PubMed ID: 6136127
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
    Reffo GC; Pitzorno G; Perin S; Forattini C
    Minerva Med; 1980 Jan; 71(1):49-54. PubMed ID: 6101911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man.
    Frisk-Holmberg M; Juhlin-Dannfelt A; Aström H
    Clin Physiol; 1985 Jun; 5(3):231-42. PubMed ID: 2860992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.